We’re delighted that NICE has approved bevacizumab for first- and second-line treatment in combination with chemotherapy for advanced bowel cancer patients in England and Wales, following a similar ...

EDX Medical is launching a bowel cancer testing service in the UK in the coming weeks that is intended to improve the ...

The overall incidence of colorectal cancer (CRC) in the United Kingdom plateaued at 67.4 per 100,000 person-years from 2000 to 2021, with slight improvements observed in overall survival, particularly ...

EDX Medical Group announces the commercial launch in the UK of a new comprehensive testing service that improves the early ...

Cases of bowel cancer in people aged 25 to 49 have risen 24 per cent in the UK since 1995, despite falling rates in older ...

The aim of the current study is to report the long-term outcomes after laparoscopic-assisted surgery compared with conventional open surgery within the context of the UK MRC CLASICC trial. Results ...

Innovent Biologics has received China’s NMPA approval for the NDA for Tabosun, a CTLA-4 monoclonal antibody for colon cancer.

The Global Healthy Living Foundation (GHLF) and Guardant Health today announced a new partnership aimed at improving public ...

Paige Seifert, 25 from Colorado, US, dismissed blood in her stool as hemorrhoids for months before a colonoscopy revealed stage three colon cancer. After surgery to remove the tumor and part of her ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks.The service increases ...